RMTI — Rockwell Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $36.44m
- $22.82m
- $101.49m
- 40
- 74
- 29
- 45
Annual cashflow statement for Rockwell Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -30.9 | -32.7 | -18.7 | -8.44 | -0.48 |
| Depreciation | |||||
| Non-Cash Items | 3.37 | 3.31 | 3.3 | 4.83 | 4.03 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.96 | -4.84 | -2.61 | -7.24 | -1.53 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -29.6 | -33.5 | -17.4 | -9.41 | 4.2 |
| Capital Expenditures | -1.05 | -0.522 | -0.281 | -12.6 | -1.01 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 4.26 | 0.833 | -2.12 | 9.6 | -3.85 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 3.21 | 0.311 | -2.4 | -3.04 | -4.87 |
| Financing Cash Flow Items | -3.89 | -0.006 | -0.191 | 0 | -1.63 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 63.3 | -2.18 | 16.6 | 11.3 | 7.35 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36.9 | -35.4 | -3.18 | -1.12 | 6.68 |